CN Patent

CN1639157A — 2－酰基氨基噻唑衍生物或其盐

Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 2005-07-13 · 21y expired

What this patent protects

基于良好的人c－mpl－Ba/F3细胞增殖作用及巨核细胞集落形成促进作用而具有血小板增多活性的2－酰基氨基噻唑衍生物或其制药学上允许的盐。对血小板减少症的治疗有用的化合物或其制药学上允许的盐。

USPTO Abstract

基于良好的人c－mpl－Ba/F3细胞增殖作用及巨核细胞集落形成促进作用而具有血小板增多活性的2－酰基氨基噻唑衍生物或其制药学上允许的盐。对血小板减少症的治疗有用的化合物或其制药学上允许的盐。

Drugs covered by this patent

avatrombopag-maleate (AVATROMBOPAG MALEATE)

Patent Metadata

Patent number: CN1639157A
Jurisdiction: CN
Classification: —
Expires: 2005-07-13
Drug substance claim: No
Drug product claim: No
Assignee: Yamanouchi Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.